# Safety Study of Liver Natural Killer Cell Therapy for Hepatoma Liver Transplantation

> **NCT01147380** · PHASE1 · COMPLETED · sponsor: **Seigo Nishida** · enrollment: 18 (actual)

## Conditions studied

- Liver Cirrhosis
- Hepatocellular Carcinoma
- Evidence of Liver Transplantation

## Interventions

- **BIOLOGICAL:** Liver NK cell inoculation

## Key facts

- **NCT ID:** NCT01147380
- **Lead sponsor:** Seigo Nishida
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2016-03-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01147380

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01147380, "Safety Study of Liver Natural Killer Cell Therapy for Hepatoma Liver Transplantation". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01147380. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*